Advanced Triple-Negative Breast Cancer
Also known as: Advanced Triple Negative Breast Cancers / Advanced Triple Negative Breast Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11945 | Avelumab | 1 | Terminated | 1 |
| DB00531 | Cyclophosphamide | 1 | Terminated | 1 |
| DB17534 | TRX-518 | 1 | Terminated | 1 |
| DB00062 | Albumin human | 1 / 2 | Not Yet Recruiting | 1 |
| DB17465 | CD-16 NK-92 cells | 1 / 2 | Terminated | 1 |
| DB00531 | Cyclophosphamide | 1 / 2 | Terminated | 1 |
| DB14844 | Dordaviprone | 1 / 2 | Withdrawn | 1 |
| DB17293 | Hiltonol | 1 / 2 | Withdrawn | 1 |
| DB16479 | Inbakicept | 1 / 2 | Terminated | 1 |
| DB01229 | Paclitaxel | 1 / 2 | Not Yet Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Withdrawn | 1 |
| DB15185 | Rasdegafusp alfa | 1 / 2 | Withdrawn | 1 |
| DB14765 | Rivoceranib | 1 / 2 | Not Yet Recruiting | 1 |
| DB12893 | Sacituzumab govitecan | 1 / 2 | Terminated | 1 |
| DB11942 | Selinexor | 1 / 2 | Recruiting | 1 |
| DB11760 | Talazoparib | 1 / 2 | Recruiting | 1 |
| DB14765 | Rivoceranib | 2 | Completed | 1 |
| DB00361 | Vinorelbine | 2 | Completed | 1 |